Adc Therapeutics Sa's ability to collect accounts receivable sequentially worsen to 2.86, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Adc Therapeutics Sa's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 128 days, from 126 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 398 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2740, from overall ranking in the first quarter 2026 at 2896.

What is Receivable Turnover Ratio?
What is Adc Therapeutics Sa Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ADCT Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	7.07 %	-2.26 %	43.32 %	-4.63 %	14.5 %
Y / Y Revenue Change	2.17 %	-9.47 %	36.36 %	-11.03 %	8.21 %
Receivable Turnover Ratio (TTM)	2.86	2.9	2.96	2.97	3.02
ADCT's Total Ranking	# 2740	# 2896	# 2197	# 2919	# 2865
Accounts Receivable average collection period days	127	126	123	123	121
Seq. Receivable Change	-9.7 %	6.62 %	27.05 %	-12.47 %	-17.56 %
Seq. Revenue Change	-7.69 %	-9.57 %	40.37 %	-12.8 %	-18.21 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 120
Healthcare Sector	# 399
Overall Market	# 2740

Receivable Turnover Ratio Statistics
High	Average	Low
0.87	0.56	0.06
(Sep. 30, 2009)		(Dec 31 2021)

ADCT Company Profile • Back to ADCT Efficiency Comparisons • Compare ADCT Receivables Turnover Ratio to its Competitors

Financial Statements
Adc Therapeutics Sa's Accounts Receivable	$ 28 Millions	Visit ADCT's Balance sheet
Adc Therapeutics Sa's Sales TTM	$ 80 Millions	Visit ADCT's Income Statement
Sources of ADCT's Revenues		Visit ADCT's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ADCT's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ADCT's Growth Rates	ADCT's Roa	ADCT's Inventory Turnover Ratio	ADCT's Dividend Comparisons
ADCT's Profitability Ratios	ADCT's Roi	ADCT's Asset Turnover Ratio	ADCT's Dividend Growth
ADCT's Valuation Ratios	ADCT's Roe	ADCT's Financial Strength Ratios	ADCT's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Castle Biosciences Inc	7.79	$ 357.278 Millions	$ 45.867 Millions
Trisalus Life Sciences Inc	7.78	$ 45.179 Millions	$ 5.808 Millions
Idexx Laboratories Inc	7.75	$ 4,553.792 Millions	$ 587.472 Millions
Vycor Medical Inc	7.68	$ 1.807 Millions	$ 0.235 Millions
Aurinia Pharmaceuticals Inc	7.67	$ 311.507 Millions	$ 40.624 Millions
Beta Bionics Inc	7.65	$ 119.513 Millions	$ 15.615 Millions
Lemaitre Vascular Inc	7.65	$ 262.923 Millions	$ 34.370 Millions
Novocure Limited	7.62	$ 699.193 Millions	$ 91.768 Millions
Natera Inc	7.61	$ 2,707.077 Millions	$ 355.618 Millions
Co diagnostics Inc	7.58	$ 0.721 Millions	$ 0.095 Millions
Quest Diagnostics Inc	7.56	$ 11,560.000 Millions	$ 1,529.250 Millions
Edap Tms Sa	7.55	$ 111.051 Millions	$ 14.699 Millions
Fortress Biotech Inc	7.55	$ 69.983 Millions	$ 9.266 Millions
Protalix Biotherapeutics inc	7.55	$ 80.619 Millions	$ 10.677 Millions
Pmgc Holdings Inc	7.55	$ 2.579 Millions	$ 0.342 Millions
Solventum Corporation	7.52	$ 8,310.000 Millions	$ 1,105.500 Millions
Iridex Corp	7.49	$ 51.044 Millions	$ 6.816 Millions
Merit Medical Systems Inc	7.48	$ 1,579.403 Millions	$ 211.171 Millions
Intuitive Surgical Inc	7.46	$ 11,296.300 Millions	$ 1,513.950 Millions
Transmedics Group Inc	7.43	$ 668.468 Millions	$ 89.962 Millions
Seres Therapeutics Inc	7.42	$ 1.883 Millions	$ 0.254 Millions
Blue Water Vaccines Inc	7.41	$ 0.646 Millions	$ 0.087 Millions
Renovorx Inc	7.40	$ 1.976 Millions	$ 0.267 Millions
Maravai Lifesciences Holdings Inc	7.39	$ 207.886 Millions	$ 28.147 Millions
Nurix Therapeutics Inc	7.35	$ 36.766 Millions	$ 5.000 Millions
Cerus Corporation	7.35	$ 221.224 Millions	$ 30.111 Millions
Anteris Technologies Global Corp	7.34	$ 2.242 Millions	$ 0.305 Millions
Palatin Technologies Inc	7.34	$ 13.185 Millions	$ 1.797 Millions
Lucid Diagnostics Inc	7.33	$ 5.445 Millions	$ 0.742 Millions
Foxo Technologies Inc	7.27	$ 24.846 Millions	$ 3.420 Millions

Date modified: 2026-10-15T05:23:37+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.